COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,704 Articles (22,913 medRxiv, 8,791 bioRxiv)

Most recent first Previous |  Page 1914: Articles 19131-19140  | Next

Profiling transcription factor sub-networks in type I interferon signaling and in response to SARS-CoV-2 infection
Chilakamarti, R.
10.1101/2021.01.25.428122 — Posted: 2021-01-25
mRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challenge
Meyer, M., Wang, Y., Edwards, D., Smith, G. R., Rubenstein, A. B., Ramanathan, P., Mire, C. E., Pietzsch, C., Chen, X., Ge, Y., Cheng, W. S., Henry, C., Woods, A., Ma, L., Stewart-Jones, G. B. E., Bock, K. W., Mahnaz, M., Nagata, B. M., Periasamy, S., Shi, P.-Y., Graham, B. S., Moore, I. N., Ramos, I., Troyanskaya, O. G., Zaslavsky, E., Carfi, A., Sealfon, S. C., Bukreyev, A.
10.1101/2021.01.25.428136 — Posted: 2021-01-25
Molecular Dynamics Reveals the Effects of Temperature on Critical SARS-CoV-2 Proteins
Morgan, P., Shu, C.-W.
10.1101/2021.01.24.427990 — Posted: 2021-01-25
Lost in translation: codon optimization inactivates SARS-CoV-2 RdRp
Wang, B., Svetlov, V., Nudler, E., Artsimovitch, I.
10.1101/2021.01.24.428004 — Posted: 2021-01-25
Effect of mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion function
Barrett, C. T., Neal, H. E., Edmonds, K., Moncman, C. L., Thompson, R., Branttie, J. M., Boggs, K. B., Wu, C.-Y., Leung, D. W., Dutch, R. E.
10.1101/2021.01.24.428007 — Posted: 2021-01-25
Next generation vaccine platform: polymersomes as stable nanocarriers for a highly immunogenic and durable SARS-CoV-2 spike protein subunit vaccine
Lam, J. H., Khan, A. K., Cornell, T. A., Dress, R. J., Chia, T. W., Yeow, W. W. W., Mohd-Ismail, N. K., Venkatraman, S., Ng, K. T., Tan, Y.-J., Anderson, D. E., Ginhoux, F., Nallani, M.
10.1101/2021.01.24.427729 — Posted: 2021-01-25
A multiscale model suggests that a moderately weak inhibition of SARS-CoV-2 replication by type I IFN could accelerate the clearance of the virus
Bouchnita, A., Tokarev, A., Volpert, V.
10.1101/2021.01.25.427896 — Posted: 2021-01-25
Ubiquitin ligase RIPLET mediates polyubiquitination of RIG-I and LGP2 and regulates the innate immune responses to SARS-CoV-2 infection
Kouwaki, T., Nishimura, T., Wang, G., Nakagawa, R., Oshiumi, H.
10.1101/2021.01.25.428042 — Posted: 2021-01-25
High-throughput sequencing of SARS-CoV-2 in wastewater provides insights into circulating variants
Fontenele, R. S., Kraberger, S., Hadfield, J., Driver, E. M., Bowes, D., Holland, L. A., Faleye, T. O. C., Adhikari, S., Kumar, R., Inchausti, R., Holmes, W. K., Deitrick, S., Brown, P., Duty, D., Smith, T., Bhatnagar, A., Yeager, R. A., Holm, R. H., Hoogesteijn von Reitzenstein, N., Wheeler, E., Dixon, K., Constantine, T., Wilson, M. A., Lim, E. S., Jiang, X., Halden, R. U., Scotch, M., Varsani, A.
10.1101/2021.01.22.21250320 — Posted: 2021-01-25
Mental health and wellbeing amongst people with informal caring responsibilities across different time points during the COVID-19 pandemic: A population-based propensity score matching analysis
Mak, H. W., Bu, F., Fancourt, D.
10.1101/2021.01.21.21250045 — Posted: 2021-01-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).